Results of a phase II trial of abiraterone acetate plus prednisone in patients with a molecular apocrine HER2-negative locally advanced or metastatic breast cancer (UCBG 2012-1)

Affiliation auteurs!!!! Error affiliation !!!!
TitreResults of a phase II trial of abiraterone acetate plus prednisone in patients with a molecular apocrine HER2-negative locally advanced or metastatic breast cancer (UCBG 2012-1)
Type de publicationJournal Article
Year of Publication2016
AuteursGrellety T., Bonnefoi H., Tredan O., Saghatchian M., Dalenc F., Mailliez A., L'Haridon T., Cottu P., Abadie-Lacourtoisie S., You B., Mousseau M., Dauba J., Del Piano F., Desmoulins I., Coussy F., Grenier J., MacGrogan G., Orsini C., Pulido M., Goncalves A.
JournalEUROPEAN JOURNAL OF CANCER
Volume57
PaginationS98
Date PublishedAPR
Type of ArticleMeeting Abstract
ISSN0959-8049